Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only be effective...
Susan Prockop, MD, discusses the risk of developing a tumor or lymphoma following a stem cell or organ transplant in patients with Epstein-Barr virus who have had a bone marrow transplant.
Hayley Adams, DVM, PhD, DACVPM, DACVM, discusses the available information on Zika virus, including potential vaccines, preventive measures, and the focus on treating symptoms.
Stevin Zorn, PhD, discusses research into exploitation of a single mechanism of action for possible treatment and prevention of Alzheimer disease, and a possible shift of focus towards experimenting with...
Santosh Kesari, MD, PhD, discusses a new prodrug that targets cells with a high level of PSMA expression, a protein that is present in many cancerous tumors.
Rashmi Roy, MD, FACS, endocrine surgeon for the University Medical Center of Princeton at Plainsboro, outlines how adrenal tumors can cause patients to display symptoms of hypertension and diabetes.
Stephanie Lehrhoff, MD, discusses factors that may influence the risk of developing hidradenitis suppurativa, including cigarette smoking, obesity, and genetics.
Stephanie Lehrhoff, MD, discusses misdiagnosis of hidradenitis suppurativa as furunculosis, which can be very dangerous for a patient because the chronicity of HS can have debilitating long-term effects if...
Juan Pablo Frias, MD, lists scores on 3 common screening tests (fasting plasma glucose, hemoglobin A1C, and 75g oral glucose tolerance) that indicates someone in an intermediary position between normal...
